Ovid Therapeutics Inc. on November 12, 2025 announced a Chief Executive Officer succession plan under which Meg Alexander will assume the role of CEO, effective January 1, 2026. Dr. Jeremy M. Levin,...
Ovid Therapeutics Inc. Announces Chief Executive Officer Changes, Effective January 1, 2026